Literature DB >> 9893378

The Marburg virus outbreak of 1967 and subsequent episodes.

W G Slenczka1.   

Abstract

Mesh：

Year:  1999        PMID： 9893378     DOI： 10.1007/978-3-642-59949-1_4

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  30 in total

1.  Clinical aspects of Marburg hemorrhagic fever.

Authors:  Masfique Mehedi; Allison Groseth; Heinz Feldmann; Hideki Ebihara
Journal:  Future Virol       Date:  2011-09       Impact factor: 1.831

2.  Rescue of recombinant Marburg virus from cDNA is dependent on nucleocapsid protein VP30.

Authors:  Sven Enterlein; Viktor Volchkov; Michael Weik; Larissa Kolesnikova; Valentina Volchkova; Hans-Dieter Klenk; Elke Mühlberger
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

3.  Activation of triggering receptor expressed on myeloid cells-1 on human neutrophils by marburg and ebola viruses.

Authors:  Mansour Mohamadzadeh; Sadie S Coberley; Gene G Olinger; Warren V Kalina; Gordon Ruthel; Claudette L Fuller; Dana L Swenson; William D Pratt; Douglas B Kuhns; Alan L Schmaljohn
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

Review 4.  Neurological Complications of Ebola Virus Infection.

Authors:  Bridgette Jeanne Billioux; Bryan Smith; Avindra Nath
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

5.  Different potential of C-type lectin-mediated entry between Marburg virus strains.

Authors:  Keita Matsuno; Noriko Kishida; Katsuaki Usami; Manabu Igarashi; Reiko Yoshida; Eri Nakayama; Masayuki Shimojima; Heinz Feldmann; Tatsuro Irimura; Yoshihiro Kawaoka; Ayato Takada
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

Review 6.  A Forgotten Episode of Marburg Virus Disease: Belgrade, Yugoslavia, 1967.

Authors:  Elizabeta S Ristanović; Nenad S Kokoškov; Ian Crozier; Jens H Kuhn; Ana S Gligić
Journal:  Microbiol Mol Biol Rev       Date:  2020-05-13       Impact factor: 11.056

7.  Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease.

Authors:  John M Dye; Andrew S Herbert; Ana I Kuehne; James F Barth; Majidat A Muhammad; Samantha E Zak; Ramon A Ortiz; Laura I Prugar; William D Pratt
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-12       Impact factor: 11.205

8.  Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections.

Authors:  Dana L Swenson; Danher Wang; Min Luo; Kelly L Warfield; Jan Woraratanadharm; David H Holman; John Y Dong; William D Pratt
Journal:  Clin Vaccine Immunol       Date:  2008-01-23

9.  The marburg virus 3' noncoding region structurally and functionally differs from that of ebola virus.

Authors:  Sven Enterlein; Kristina M Schmidt; Michael Schümann; Dominik Conrad; Verena Krähling; Judith Olejnik; Elke Mühlberger
Journal:  J Virol       Date:  2009-02-18       Impact factor: 5.103

10.  Severe Meningoencephalitis in a Case of Ebola Virus Disease: A Case Report.

Authors:  Daniel S Chertow; Avindra Nath; Anthony F Suffredini; Robert L Danner; Daniel S Reich; Rachel J Bishop; Richard W Childs; Andrew E Arai; Tara N Palmore; H Clifford Lane; Anthony S Fauci; Richard T Davey
Journal:  Ann Intern Med       Date:  2016-04-05       Impact factor: 25.391
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.